Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
12/2005
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1049466B1 Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
12/07/2005EP0949920B1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
12/07/2005CN1705668A Heterocyclocarboxamide derivatives
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230416C Pharmaceutical compounds
12/07/2005CN1230178C Remedies for bladder irritation signs in association with prostatauxe
12/07/2005CN1230176C Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2,3-D] pyrimidine for treatment of pain
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/01/2005WO2005113560A2 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AS PROTEIN KINASE INHIBITORS
12/01/2005WO2005113559A1 Stereoselective method for the production of clopidogrel
12/01/2005WO2005113536A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/01/2005WO2004085401A8 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267099 Reacting a des-piperazine olanzapine with an N-formyl piperazine to form an N-formyl olanzapine
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005DE102004024271A1 Verbindungen enthaltend 3,4-Methylendioxythiophen-Einheiten Compounds containing 3,4-methylenedioxythiophene units
12/01/2005CA2564530A1 Thieno[3,2-b]pyridine-6-carbonitriles as protein kinase inhibitors
12/01/2005CA2563662A1 A stereoselectivce process for the preparation of clopidogrel
11/2005
11/30/2005EP1599469A1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
11/30/2005EP1599461A1 Thiolactones
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/24/2005WO2005111046A1 Thienopyridine derivatives, production method and use thereof
11/24/2005WO2005111045A1 MONO-, OLIGO- AND POLYTHIENO[3,2-b]THIOPHENES
11/24/2005WO2005111039A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
11/24/2005WO2005111007A1 Thiazole compound and use thereof
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110410A2 Kinase inhibitors as therapeutic agents
11/24/2005US20050261356 Methods and compositions for the treatment of chronic lymphocytic leukemia
11/24/2005US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/24/2005US20050258398 Dithia-s-indacene derivative
11/24/2005CA2566625A1 Thiazole compound and use thereof
11/24/2005CA2566421A1 Thienopyridine derivatives, production method and use thereof
11/24/2005CA2566158A1 Kinase inhibitors as therapeutic agents
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1598877A1 Switching element
11/23/2005EP1598358A1 compounds comprising 3,4-methylendioxythiophene units
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/23/2005CN1699347A Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
11/22/2005US6967216 Neuropeptide Y receptor modulators; treating eating disorders
11/22/2005US6967207 Preventive or therapeutic agents for gastric or esophageal regurgitation
11/17/2005WO2005108390A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/17/2005WO2005108388A1 Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents
11/17/2005WO2005107375A2 Process for the preparation of olanzapine form-i
11/17/2005WO2005095401A8 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
11/17/2005WO2005080890A9 Pharmacologically acceptable salts of clopidogrel
11/17/2005US20050256309 Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands
11/17/2005US20050256185 Spiro and dispiro 1,2,4-trioxolane antimalarials
11/17/2005US20050256178 Novel nutraceutical compositions comprising boitin
11/17/2005US20050256153 Thienopyridinone compounds and methods of treatment
11/17/2005US20050256152 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/17/2005US20050256140 Condensed pyridines and pyrimidines with tie2 (tek) activity
11/17/2005US20050256124 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
11/17/2005US20050256121 Substituted 2,5-heterocyclic derivatives
11/17/2005US20050256104 Protease inhibitors
11/17/2005US20050256102 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine
11/17/2005US20050256099 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/17/2005US20050256048 Selective androgen receptor modulators and methods for their identification, design and use
11/17/2005CA2566426A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/17/2005CA2565061A1 Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents
11/16/2005EP1596444A1 Rectifier element
11/16/2005EP1595884A2 Salt of sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/16/2005EP1594879A1 Process and intermediates for the preparation of olanzapine
11/16/2005EP1594873A1 Pyrrolidinohydrochinazolines
11/16/2005EP1594495A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/16/2005EP1476429B1 Novel pyridine- and quinoline-derivatives
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1257550B1 Platelet adp receptor inhibitors
11/16/2005EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
11/16/2005CN1696132A Compound comprising 3,4-methylendioxythiophene units
11/15/2005US6964961 Antiproliferative agents for mammals
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/15/2005CA2288637C Process for the preparation of 2-[(2-thienyl)-ethylamino-(2-halogenophe nyl)-acetonitriles
11/15/2005CA2248802C Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same
11/10/2005WO2005105809A1 Thienopyridines as ikk inhibitors
11/10/2005WO2005105808A1 Thienopyridazines as ikk inhibitors
11/10/2005WO2005105805A1 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof
11/10/2005WO2005105765A1 Nitric oxide donors and uses thereof
11/10/2005WO2005105760A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005WO2005105065A2 Thiazole-based nitric oxide donors for treating inflammatory bowel diseases
11/10/2005WO2005104663A2 Industrial process for preparation of clopidogrel hydrogen sulphate
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus
11/10/2005US20050250793 Preventives/remedies for hot flash
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250765 Diazepinones as antiviral agents
11/10/2005US20050250763 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/10/2005US20050250751 neo-tanshinlactone is excluded; treating cancer
1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 214